Our main finding is that developmental exposure to DE-71 produces significant glucose dysregulation including fasting hyperglycemia, impaired glucose tolerance, insulin insensitivity and delayed glucose clearance/utilization in response to insulin; all symptoms used clinically to diagnose diabetes and validate diabetic animal models44. This evidence concerns the gene INS and diabetes mellitus.